| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Normal phase NEGATIVE ION MODE | ATQ-20180530 | Drug treatment:Atovaquone, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ATQ-20181025 | Drug treatment:Atovaquone, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ATQ-MB1 | Drug treatment:Atovaquone, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ATQ-MB2 | Drug treatment:Atovaquone, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | MMV009108-20180530 | Drug treatment:MMV009108, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | MMV009108-MB2 | Drug treatment:MMV009108, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | MMV019662-20180530 | Drug treatment:MMV019662, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | MMV019662-MB1 | Drug treatment:MMV019662, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | MMV028038-20180530 | Drug treatment:MMV028038, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | MMV028038-20181025 | Drug treatment:MMV028038, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ND-20180530 | Drug treatment:Untreated, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ND-20181025 | Drug treatment:Untreated, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ND-MB1 | Drug treatment:Untreated, 2.5 hours | Peak Area Post-Blank Subtraction |
| Normal phase NEGATIVE ION MODE | ND-MB2 | Drug treatment:Untreated, 2.5 hours | Peak Area Post-Blank Subtraction |
Return to study ST001149 main page
Download data matrix(Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Normal phase NEGATIVE ION MODE)
- Metabolomics Workbench
|